Dieses Anti-SNCA-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von SNCA in WB. Geeignet für Human, Maus, Ratte, Rind (Kuh), Hund und Non-Human Primate.
1 image
Produktnummer ABIN372588
Kurzübersicht für SNCA Antikörper (pSer129) (ABIN372588)
Recognizes the ~15 kDa alpha-Synuclein protein phosphorylated at Ser129. Immunolabeling is blocked by the phosphopeptide used as antigen but not by the corresponding dephosphopeptide.
Kreuzreaktivität (Details)
Species reactivity (expected):Bovine, Canine, Human, Mouse and non-Human Primates. Species reactivity (tested):Rat.
Aufreinigung
Affinity Chromatography.
Immunogen
Phosphopeptide corresponding to amino acid residues surrounding the phospho-Ser129 of alpha Synuclein.
Western Blot: 1/1000. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg/mL BSA and 50 % Glycerol.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store the antibody undiluted (in aliquots) at-20 °C.
Target
SNCA
(Synuclein, alpha (SNCA))
Andere Bezeichnung
alpha-Synuclein / SNCA
Hintergrund
Alpha-synuclein is a presynaptic neuronal protein that is thought to be involved in the formation of SNARE complexes. Most significantly, aggregated alpha-synuclein is one of the major components found in the Lewy bodies that occur in Parkinson's disease (PD) and other neurodegenerative disorders (Okochi et al., 2000). Mutation of the alpha-synuclein gene is associated with familial forms of PD (Newmann et al., 2002). Recent evidence suggests that phosphorylation of alpha-synuclein at ser129 plays a role in the formation of inclusions in PD (Smith et al., 2005, Masliah et al., 2005).Synonyms: NACP, Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor, PARK1